What’s New?

In the News

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

Expanding industry leading electronic clinical surveillance solutions to approximately 1,000 facilities. • Strategic combination positioned to drive quality outcomes improvement beyond current health information technology capabilities • Complementary data analytics and real-time surveillance expertise will support next-generation predictive clinical apps on an integrated technology platform • Expands Premier’s footprint by approximately 400 unaffiliated facilities • Provides opportunity to expand relationships with academic medical centers

For Immediate Release

Charlotte, N.C. (August 05, 2014)

Download PDF

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions.

TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier’s board of directors unanimously approved

Continue reading

New article in Infection Control and Hospital Epidemiology concludes TheraDoc alerting combined with antimicrobial stewardship intervention has multiple postive effects

The following article appears in the February 2014 issue of Infection Control and Hospital Epidemiology (2014;35(2):132-138).

The article illustrates how TheraDoc’s active alerting was used in combination with antimicrobial stewardship interventions on patients with gram-negative bacteremia. The study discussed in this article was a quasi-experimental retrospective cohort study conducted at three hospitals within Detroit Medical Center, with a combined 1,100 beds. Data resulting from active alerting of a positive blood culture coupled with stewardship intervention was compiled during 2010–2011 and compared to data from patients who received no formalized stewardship intervention during 2009.

This study found that the approach taken by the antimicrobial stewardship program (ASP) at these hospitals resulted in reductions in time-to-appropriate therapy (TTAT), length-of-stay (LOS), and infection-related mortality for patients with gram-negative bacteremia who were not on appropriate empiric therapy at the time of a positive culture alert.

To download a

Continue reading


APIC 2014 – Anaheim
APIC 2014 – Anaheim

See us at booth #140 June 7th thru June 9th